# Sutro Biopharma, Inc.: Form 8-K, filed Mar 25, 2024

- Company: [Sutro Biopharma, Inc.](/companies/stro.md) (CIK 1382101)
- Form: 8-K
- Filed: 2024-03-25
- Accepted by EDGAR: Mar 25, 2024, 16:30 ET
- Period: 2024-03-25
- Accession: 0000950170-24-035948
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1382101/000095017024035948/stro-20240325.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1382101/000095017024035948/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1382101/000095017024035948/stro-20240325.htm

Filed Mar 25, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-035948. Last ingested by Listed: Oct 24, 2026, 15:12 ET. No prices; not investment advice.